Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Penson

Showing results (521-530 of 570) with videos related to

Pageof 57
Sort By:
Journal of Comparative Effectiveness Research|November 19, 2013
Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR studyDaniel A Barocas, Vivien Chen, Matthew Cooperberg, et al.
The New England Journal of Medicine|May 30, 2020
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate CancerCora N Sternberg, Karim Fizazi, Fred Saad, et al.
European Urology|November 7, 2016
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR StudyMark D Tyson, JoAnn Alvarez, Tatsuki Koyama, et al.
Annals of Internal Medicine|November 29, 2017
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance CohortsLurdes Y T Inoue, Daniel W Lin, Lisa F Newcomb, et al.
American Journal of Epidemiology|January 29, 2019
Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Recruitment Efforts for Population-Based StudiesMorgan M Millar, Anita Y Kinney, Nicola J Camp, et al.
Cancer|October 23, 2019
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohortsJane M Lange, Aaron A Laviana, David F Penson, et al.
European Urology|March 5, 2018
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsMark Douglas Tyson, Tatsuki Koyama, Dan Lee, et al.
Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.
JAMA|March 22, 2017
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsDaniel A Barocas, JoAnn Alvarez, Matthew J Resnick, et al.
European Urology|February 27, 2020
Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or ObservationAaron A Laviana, Zhiguo Zhao, Li-Ching Huang, et al.
Pageof 57

Showing results (521-530 of 570) with videos related to

Sort By:
Pageof 57
Journal of Comparative Effectiveness Research|November 19, 2013
Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR studyDaniel A Barocas, Vivien Chen, Matthew Cooperberg, et al.
The New England Journal of Medicine|May 30, 2020
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate CancerCora N Sternberg, Karim Fizazi, Fred Saad, et al.
European Urology|November 7, 2016
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR StudyMark D Tyson, JoAnn Alvarez, Tatsuki Koyama, et al.
Annals of Internal Medicine|November 29, 2017
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance CohortsLurdes Y T Inoue, Daniel W Lin, Lisa F Newcomb, et al.
American Journal of Epidemiology|January 29, 2019
Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Recruitment Efforts for Population-Based StudiesMorgan M Millar, Anita Y Kinney, Nicola J Camp, et al.
Cancer|October 23, 2019
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohortsJane M Lange, Aaron A Laviana, David F Penson, et al.
European Urology|March 5, 2018
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study ResultsMark Douglas Tyson, Tatsuki Koyama, Dan Lee, et al.
Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.
JAMA|March 22, 2017
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsDaniel A Barocas, JoAnn Alvarez, Matthew J Resnick, et al.
European Urology|February 27, 2020
Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or ObservationAaron A Laviana, Zhiguo Zhao, Li-Ching Huang, et al.
Pageof 57